Hepion pharmaceuticals to present two posters at easl international liver congress™ 2023

- preclinical studies demonstrate rencofilstat may protect against nash/nafld, shift the liver transcriptome and lipidome toward nash resolution –
HEPA Ratings Summary
HEPA Quant Ranking